This nomogram (Figure 8C) provides a visual tool for estimating the probability of 1-year, 3-year, and 5-year survival rates based on cumulative scores derived from multiple prognostic factors, such as SLC22A3 expression, age, gender, and tumor stage. This evidence concerns the gene SLC22A3 and neoplasm.